Novaminsulfon 500 (Metamizole Sodium Monohydrate)

Metamizole sodium works by inhibiting cyclooxygenase enzymes, which lowers prostaglandin production, and by influencing endogenous opioid pathways in the central nervous system. This dual action reduces inflammation‑mediated pain signals and produces a fever‑lowering effect, although the exact molecular details are not fully clarified.

The appropriate dose of Novaminsulfon 500 is determined by the prescribing healthcare professional based on the individual’s clinical condition, severity of symptoms, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for metamizole sodium during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and only under the direction of a qualified healthcare provider.

To order Novaminsulfon 500, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Novaminsulfon (metamizole) differs from traditional NSAIDs by having a distinct pyrazolone structure and a lower incidence of gastrointestinal irritation, but it carries a unique risk of blood dyscrasias such as agranulocytosis. Compared with opioids, it provides analgesia without typical opioid‑related respiratory depression, making it a useful alternative in certain clinical scenarios.

Novaminsulfon 500 tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.

Novaminsulfon 500 is administered orally, typically as a whole tablet swallowed with water. The exact administration schedule, including timing relative to meals, is determined by the prescribing clinician based on the therapeutic need.

The most serious adverse reactions associated with Novaminsulfon 500 include agranulocytosis, which can lead to severe infection, and hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should be monitored for signs of infection, skin eruptions, or respiratory distress and seek immediate medical attention if these occur.

Novaminsulfon 500 should be avoided in individuals with a known hypersensitivity to metamizole or other pyrazolones, those with a history of agranulocytosis or severe blood dyscrasias, and patients with severe hepatic or renal impairment unless specifically directed by a physician.